Literature DB >> 19587641

NKT cells in mucosal immunity.

S Middendorp1, E E S Nieuwenhuis.   

Abstract

The gastrointestinal tract allows the residence of an almost enumerable number of bacteria. To maintain homeostasis, the mucosal immune system must remain tolerant to the commensal microbiota and eradicate pathogenic bacteria. Aberrant interactions between the mucosal immune cells and the microbiota have been implicated in the pathogenesis of inflammatory disorders, such as inflammatory bowel disease (IBD). In this review, we discuss the role of natural killer T cells (NKT cells) in intestinal immunology. NKT cells are a subset of non-conventional T cells recognizing endogenous and/or exogenous glycolipid antigens when presented by the major histocompatibility complex (MHC) class I-like antigen-presenting molecules CD1d and MR1. Upon T-cell receptor (TCR) engagement, NKT cells can rapidly produce various cytokines that have important roles in mucosal immunity. Our understanding of NKT-cell-mediated pathways including the identification of specific antigens is expanding. This knowledge will facilitate the development of NKT cell-based interventions and immune therapies for human intestinal diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19587641     DOI: 10.1038/mi.2009.99

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  33 in total

Review 1.  Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors?

Authors:  Jot Hui Ooi; Jing Chen; Margherita T Cantorna
Journal:  Mol Aspects Med       Date:  2011-11-06

2.  Mechanisms of immune tolerance relevant to food allergy.

Authors:  Brian P Vickery; Amy M Scurlock; Stacie M Jones; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2011-01-31       Impact factor: 10.793

Review 3.  Mucosal control of the intestinal microbial community.

Authors:  Sylvia Brugman; Edward E S Nieuwenhuis
Journal:  J Mol Med (Berl)       Date:  2010-06-04       Impact factor: 4.599

4.  Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13.

Authors:  C S De Paiva; J K Raince; A J McClellan; K P Shanmugam; S B Pangelinan; E A Volpe; R M Corrales; W J Farley; D B Corry; D-Q Li; S C Pflugfelder
Journal:  Mucosal Immunol       Date:  2010-12-22       Impact factor: 7.313

Review 5.  Innate-like lymphocytes in intestinal infections.

Authors:  Michael S Bennett; June L Round; Daniel T Leung
Journal:  Curr Opin Infect Dis       Date:  2015-10       Impact factor: 4.915

Review 6.  Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunity.

Authors:  Amelia R Hofstetter; Lucy C Sullivan; Aron E Lukacher; Andrew G Brooks
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

7.  Intestinal iNKT cells migrate to liver and contribute to hepatocyte apoptosis during alcoholic liver disease.

Authors:  Kuei-Chuan Lee; Peng Chen; Igor Maricic; Tatsuo Inamine; Jingjuan Hu; Shenhai Gong; Julia C Sun; Suryasarathi Dasgupta; Han-Chieh Lin; Yi-Tsung Lin; Rohit Loomba; Peter Stärkel; Vipin Kumar; Bernd Schnabl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-02-28       Impact factor: 4.052

8.  Preferential depletion of gut CD4-expressing iNKT cells contributes to systemic immune activation in HIV-1 infection.

Authors:  F J Ibarrondo; S B Wilson; L E Hultin; R Shih; M A Hausner; P M Hultin; P A Anton; B D Jamieson; O O Yang
Journal:  Mucosal Immunol       Date:  2012-11-14       Impact factor: 7.313

9.  Regulatory B cells in autoimmune diseases and mucosal immune homeostasis.

Authors:  Xiaoxiao Li; Jonathan Braun; Bo Wei
Journal:  Autoimmunity       Date:  2010-08-11       Impact factor: 2.815

10.  NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series.

Authors:  Adnan Mansoor; Stefania Pittaluga; Paul L Beck; Wyndham H Wilson; Judith A Ferry; Elaine S Jaffe
Journal:  Blood       Date:  2010-10-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.